Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q1 2025 · 10-Q
Revenue$267.14M$267.14M−4.4% vs Q1 2024 Net Income$49.07M$49.07M−7.9% vs Q1 2024 EPS Diluted$0.98$0.98−7.5% vs Q1 2024 Gross Profit$146,022,000−5.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flow$54,776,000+13.9% Free Cash Flowderived$53,624,000+15.0% Margins · derivedGross margin54.7%−0.7 pt vs Q1 2024
Operating margin27.0%−3.5 pt vs Q1 2024
Net margin18.4%−0.7 pt vs Q1 2024
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end